You're reading the free version. Trader adds the live tape and alerts.
Start tracking
XENE Exercise Disclosure
Gannon Steven · SEC Form 4 · Filed Jun 3, 2026
Exercise
Reported value range
Not reported
Gannon Steven Director
XENE
Transaction date
Jun 1, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed 2 days later
XENE daily price context
Close on/before transaction
$53.41
Jun 1, 2026
First close after public filing
$52.99
Jun 4, 2026
30-day return after filing
+14.25%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 2,645 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-256121
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$75.63K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Xenon Pharmaceuticals Inc. XENE | Award | Jun 3, 2026 | $0 |
| Xenon Pharmaceuticals Inc. XENE | Award | Jun 3, 2026 | $0 |
| Xenon Pharmaceuticals Inc. XENE | Exercise | Jun 1, 2026 | $0 |
| Xenon Pharmaceuticals Inc. XENE Current | Exercise | Jun 1, 2026 | Not reported |
| Xenon Pharmaceuticals Inc. XENE | Disposition | Jun 1, 2026 | $75.63K |